New Study Reveals Canagliflozin’s Role in Eliminating Senescent Cells: A Novel Approach to Diabetes Treatment
New research published in the journal “Nature Communications” sheds light on a potential new function of Canagliflozin, a widely used sodium-glucose co-transporter 2 (SGLT2) inhibitor …